Physician profile
Nouri Al Khaled
NPI 1760416713
$164,321.80
in general payments reported to CMS, 2019-2025
41 companies · $29K in 2025
The $29K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $12K · 2021: $15K · 2022: $27K · 2023: $14K · 2024: $34K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $56K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $3,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,250.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,440.00 |
| Food and Beverage | $3,757.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $88,185.43 | 2019-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Medtronic, INC. | $47,496.74 | 2021-2025 | Venaseal, Abre, In.Pact Admiral |
| Medtronic Vascular, INC. | $18,381.59 | 2019-2020 | |
| Philips North America LLC | $3,556.13 | 2019-2024 | (Ck4) Mcot |
| Janssen Pharmaceuticals, INC | $972.93 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $700.03 | 2019-2025 | |
| Amgen INC. | $614.79 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $605.98 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $489.14 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $482.40 | 2019-2025 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals Lp | $473.90 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Pfizer INC. | $468.58 | 2019-2025 | |
| Novo Nordisk INC | $343.67 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Actelion Pharmaceuticals US, INC. | $220.08 | 2021-2023 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $185.66 | 2019-2023 | Lifevest |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $166.75 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tactile Systems Technology INC | $127.55 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Esperion Therapeutics, INC. | $108.58 | 2021-2025 | Nexletol |
| Atricure, INC. | $92.64 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $68.86 | 2020 | |
| Alnylam Pharmaceuticals INC. | $56.48 | 2021-2025 | Onpattro |
| Angiodynamics, INC. | $46.13 | 2025 | Alphavac |
| Inspire Medical Systems, INC. | $40.62 | 2024 | Inspire |
| Kowa Pharmaceuticals America, INC. | $39.40 | 2019 | |
| Sanofi-Aventis U.S. LLC | $38.55 | 2019-2020 | |
| Scpharmaceuticals INC. | $38.42 | 2023 | |
| Terumo Medical Corporation | $30.45 | 2023 | Angio-Seal |
| Teleflex LLC | $29.50 | 2024 | Turnpike |
| Cardiovascular Systems INC. | $27.97 | 2019 | |
| Biotronik INC. | $27.42 | 2024 | Pulsar-18 T3, Passeo-18 |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $26.60 | 2019 | |
| Edwards Lifesciences Corporation | $23.13 | 2025 | Sapien 3 Ultra Resilia |
| Imperative Care, INC | $21.10 | 2025 | Symphony Catheter |
| Daiichi Sankyo INC. | $20.95 | 2024 | Injectafer |
| Abbott Laboratories | $19.85 | 2025 | Amplatzer |
| Regeneron Healthcare Solutions, INC. | $19.58 | 2019 | |
| Cordis US Corp. | $16.88 | 2022 | |
| Ge Healthcare | $16.17 | 2019 | |
| Lundbeck LLC | $14.31 | 2019 | |
| Jubilant Draximage INC. | $13.77 | 2022 | |
| Merck Sharp & Dohme LLC | $13.09 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nouri Al Khaled listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.